Literature DB >> 26781550

Cannabis and Psychosis: a Critical Overview of the Relationship.

Charles Ksir1, Carl L Hart2,3,4,5.   

Abstract

Interest in the relationship between cannabis use and psychosis has increased dramatically in recent years, in part because of concerns related to the growing availability of cannabis and potential risks to health and human functioning. There now exists a plethora of scientific articles addressing this issue, but few provide a clear verdict about the causal nature of the cannabis-psychosis association. Here, we review recent research reports on cannabis and psychosis, giving particular attention to how each report provides evidence relating to two hypotheses: (1) cannabis as a contributing cause and (2) shared vulnerability. Two primary kinds of data are brought to bear on this issue: studies done with schizophrenic patients and studies of first-episode psychosis. Evidence reviewed here suggests that cannabis does not in itself cause a psychosis disorder. Rather, the evidence leads us to conclude that both early use and heavy use of cannabis are more likely in individuals with a vulnerability to psychosis. The role of early and heavy cannabis use as a prodromal sign merits further examination, along with a variety of other problem behaviors (e.g., early or heavy use of cigarettes or alcohol and poor school performance). Future research studies that focus exclusively on the cannabis-psychosis association will therefore be of little value in our quest to better understand psychosis and how and why it occurs.

Entities:  

Keywords:  Cognition; Marijuana; Mental illness; Psychotic disorder; Schizophrenia; THC

Mesh:

Year:  2016        PMID: 26781550     DOI: 10.1007/s11920-015-0657-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  65 in total

1.  Violence of young criminals predicts schizophrenia: a 9-year register-based followup of 15- to 19-year-old criminals.

Authors:  Niels Patrick Gosden; Peter Kramp; Gorm Gabrielsen; Tavs Folmer Andersen; Dorte Sestoft
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

2.  Cannabis use and genetic predisposition for schizophrenia: a case-control study.

Authors:  W Veling; J P Mackenbach; J van Os; H W Hoek
Journal:  Psychol Med       Date:  2008-05-19       Impact factor: 7.723

3.  Profiles of substance use disorders in patients of therapeutic communities: link to social, medical and psychiatric characteristics.

Authors:  David Fernández-Calderón; Fermín Fernández; Sofía Ruiz-Curado; Antonio Verdejo-García; Óscar M Lozano
Journal:  Drug Alcohol Depend       Date:  2015-01-20       Impact factor: 4.492

4.  Comorbidity of severe psychotic disorders with measures of substance use.

Authors:  Sarah M Hartz; Carlos N Pato; Helena Medeiros; Patricia Cavazos-Rehg; Janet L Sobell; James A Knowles; Laura J Bierut; Michele T Pato
Journal:  JAMA Psychiatry       Date:  2014-03       Impact factor: 21.596

5.  The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).

Authors:  Sarah Tosato; Antonio Lasalvia; Chiara Bonetto; Rodolfo Mazzoncini; Doriana Cristofalo; Katia De Santi; Mariaelena Bertani; Sarah Bissoli; Lorenza Lazzarotto; Giovanna Marrella; Dario Lamonaca; Rosanna Riolo; Francesco Gardellin; Anna Urbani; Michele Tansella; Mirella Ruggeri
Journal:  J Psychiatr Res       Date:  2013-01-04       Impact factor: 4.791

6.  Cannabis use and family history in adolescent first episode psychosis in Durban, South Africa.

Authors:  Saeeda Paruk; Jonathan K Burns; Rochelle Caplan
Journal:  J Child Adolesc Ment Health       Date:  2013

7.  Hemispheric language asymmetry in first episode psychosis and schizotypy: the role of cannabis consumption and cognitive disorganization.

Authors:  Daniela A Herzig; Sarah Sullivan; Glyn Lewis; Rhiannon Corcoran; Richard Drake; Jonathan Evans; David Nutt; Christine Mohr
Journal:  Schizophr Bull       Date:  2014-12-27       Impact factor: 9.306

8.  Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders.

Authors:  Laura Koenders; Marise W J Machielsen; F J van der Meer; Angelique C M van Gasselt; Carin J Meijer; Wim van den Brink; Maarten W J Koeter; Matthan W A Caan; Janna Cousijn; Anouk den Braber; Dennis van 't Ent; Maaike M Rive; Aart H Schene; Elsmarieke van de Giessen; Chaim Huyser; Bart P de Kwaasteniet; Dick J Veltman; Lieuwe de Haan
Journal:  J Psychiatry Neurosci       Date:  2015-05       Impact factor: 6.186

9.  Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.

Authors:  David W Volk; Stephen M Eggan; Andrew G Horti; Dean F Wong; David A Lewis
Journal:  Schizophr Res       Date:  2014-08-05       Impact factor: 4.939

10.  Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

Authors:  Marta Di Forti; Hannah Sallis; Fabio Allegri; Antonella Trotta; Laura Ferraro; Simona A Stilo; Arianna Marconi; Caterina La Cascia; Tiago Reis Marques; Carmine Pariante; Paola Dazzan; Valeria Mondelli; Alessandra Paparelli; Anna Kolliakou; Diana Prata; Fiona Gaughran; Anthony S David; Craig Morgan; Daniel Stahl; Mizanur Khondoker; James H MacCabe; Robin M Murray
Journal:  Schizophr Bull       Date:  2013-12-17       Impact factor: 9.306

View more
  28 in total

Review 1.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

2.  Cannabis Use, Polysubstance Use, and Psychosis Spectrum Symptoms in a Community-Based Sample of U.S. Youth.

Authors:  Jason D Jones; Monica E Calkins; J Cobb Scott; Emily C Bach; Raquel E Gur
Journal:  J Adolesc Health       Date:  2017-03-17       Impact factor: 5.012

Review 3.  Cannabinoids and glial cells: possible mechanism to understand schizophrenia.

Authors:  Valéria de Almeida; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-02-01       Impact factor: 5.270

Review 4.  Cannabis use in individuals at clinical high-risk for psychosis: a comprehensive review.

Authors:  Megan S Farris; Mohammed K Shakeel; Jean Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-12-03       Impact factor: 4.328

5.  The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis.

Authors:  Emily E Carol; Robert L Spencer; Vijay A Mittal
Journal:  Psychoneuroendocrinology       Date:  2017-05-30       Impact factor: 4.905

Review 6.  Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases.

Authors:  Mary-Ann Fitzcharles; Winfried Häuser
Journal:  Curr Rheumatol Rep       Date:  2016-12       Impact factor: 4.592

7.  Is smoking tobacco associated with psychotic experiences across racial categories in the United States? Findings from the Collaborative Psychiatric Epidemiological Surveys.

Authors:  Hans Y Oh; Ai Koyanagi; Fiza Singh; Jordan DeVylder
Journal:  Psychiatry Res       Date:  2016-09-15       Impact factor: 3.222

8.  Longitudinal Studies on the Etiology of Cannabis Use Disorder: A Review.

Authors:  Kelly E Courtney; Margie Hernandez Mejia; Joanna Jacobus
Journal:  Curr Addict Rep       Date:  2017-05-06

9.  Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions.

Authors:  Lauren R Pacek; Andrea H Weinberger; Jiaqi Zhu; Renee D Goodwin
Journal:  Addiction       Date:  2019-12-20       Impact factor: 6.526

10.  Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.

Authors:  Robin M Murray; Harriet Quigley; Diego Quattrone; Amir Englund; Marta Di Forti
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.